As Health Canada previously
communicated, Alere Inc. is withdrawing the Alere INRatio
® and INRatio
® 2 Prothrombin Time (PT) Monitoring Systems (professional use and patient self-test) devices from the Canadian market. These devices measure blood clotting time in patients requiring warfarin and other oral blood-thinning medicines.
There is a risk that the Alere devices provide an inaccurate low reading. This could result in an improper dosage of warfarin or other blood-thinning medications being administered, leading to excessive bleeding, which may result in serious health concerns that could potentially be fatal.
Alere INRatio® and INRatio® 2 PT/INR Monitoring Systems:
-
INRatio Patient Self-Test Kit
-
INRatio PT Professional Kit
-
INRatio 2 Prothrombin Time (PT) Monitoring System, Professional Use
-
INRatio 2 Prothrombin Time (PT) Monitoring System, Patient Self-Test
-
INRatio/INRatio 2 Prothrombin Time/INR Test Strips
Patients and healthcare professionals using the Alere INRatio® and INRatio® 2 PT professional use and self-test use monitoring systems to determine INR levels for monitoring the effect of warfarin on clotting time.
Health Canada is communicating this information to healthcare professionals and to the public. Health Canada is working with the manufacturer and closely monitoring the situation and the implementation of necessary corrective and preventative actions.
-
Call toll-free at 1-866-234-2345
-
Visit MedEffect Canada's web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.
Stay connected with Health Canada and receive the latest advisories and product recalls using
social media tools.
Health Canada
(613) 957-2983
(613) 957-2991
1-866 225-0709